Figure 1: Patients adherence to the treatment with Fitostimoline® vaginal cream and Fitostimoline® pessaries
Figure 2:TSS evaluation for treatment with both Fitostimoline ® pessaries and Fitostimoline® vaginal cream
Figure 3:TSS variation in patients treated with Fitostimoline® pessaries and Fitostimoline® vaginal cream
Figure 4:Symptoms variation after treatment with Fitostimoline® pessaries
Figure 5:Symptoms variation after treatment with Fitostimoline® vaginal cream
Figure 6: Evaluation of the satisfaction to the treatment with Fitostimoline® pessaries and vaginal cream
Pessaries (N = 34)
cream (N = 38)
p value
Age (years)
51.4±11.0
53.2±10.3
NS
Menopause (months)
32.0±34.5
37.5±31.7
Table 1: Patient demographic characteristics
Cream (N = 38)
Physiological (%)
93.1
89.6
Surgical (%)
4.7
6.3
Pharmacological (%)
2.2
4.1
Table 2: Menopause origin
Tables at a glance